Generic drug companies could ask the FDA whether their product matches the brand-name drug it copies. If it does not match, the FDA would have to explain which inactive ingredients differ and by how much.
Modern Action explains what the legislation does, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications is a House bill in Congress.
Who this affects: This bill mainly affects generic drug companies that need FDA answers before or during a generic drug application. It also affects the FDA, because the agency would have new duties to explain sameness decisions and write guidance. Brand-name drug makers could be affected because the bill allows the FDA to share more information about how proposed generics compare with their listed drugs. Patients could be affected later if the changes make some generic drugs easier or faster to develop, but the bill does not promise lower prices or wider access.
Why this matters: Generic drug makers can lose time and money when they do not know exactly why the FDA thinks their product does not match a brand-name drug. This bill would make the FDA give clearer answers about inactive ingredients and amounts. That could reduce guesswork and repeated changes during development. The real effect on drug supply, prices, or patient access would depend on how the FDA uses the new rules and how companies respond.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Keep acting on Modern Action
Compare the broader issue and related bills without leaving Modern Action.
Officially: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications
Generic drug companies could ask the FDA whether their product matches the brand-name drug it copies. If it does not match, the FDA would have to explain which inactive ingredients differ and by how much.
Use this page to support, oppose, or ask Congress to amend HR3839. Modern Action explains what the bill does, helps identify the right senators or representative, and drafts a bill-specific message you can edit and send.
Where it stands
Sitting in House Committee
No vote scheduled. Constituent contact is what moves bills out of committee.
↓ Why your message matters here
This bill is sitting in committee with no scheduled vote — which means a small number of constituent messages can decide whether it moves forward or quietly dies.
Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.
Where this bill is in the process
Introduced
Introduced in House
House Committee
Under House committee consideration
House Floor Vote
Voted on by House
Passed House
Approved by House
Senate Review
Sent to Senate for consideration
Passed Both Chambers
Approved by both House and Senate
Signed into Law
Signed by the President
For more detail
Choose one clear position: support, oppose, or amend. Then pick any reasons or personal context you want included. Modern Action uses that input and the bill context to draft a message you can edit and send.
Congressional offices prioritize messages from their own constituents. Modern Action uses your address to route the drafted message to your House representative when that is the most relevant target for this bill.
The draft includes the bill number, your position, the reasons you selected, any personal context you added, and a direct ask such as voting yes, voting no, cosponsoring, opposing, or seeking changes. You stay in control because you can edit the message before sending.
This page gives you an opportunity to support, oppose, or ask for changes to To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications, then contact the elected officials who can act. Modern Action drafts the message from your position and the reasons you select.
Modern Action keeps the action tied to the bill itself: what it does, where it is in the process (introduced), which office can still act, and what ask belongs in the message.
You are not starting from a blank form. Modern Action drafts the message around HR3839, your stance, and the reasons you choose, then lets you edit and send when ready.
